Following priority review, the FDA approved Kerendia for the treatment of patients with heart failure with left ventricular ejection fraction (LVEF) ≥40%.

Adding anxiety disorders as a qualifying condition for medical cannabis in Pennsylvania was associated with an increase in certifications.

HealthDay News — Racial/ethnic and socioeconomic disparities contribute to frequent emergency department visits for seizures, according to a study published online July 5 in Epilepsia.

The FDA has updated the labeling for Kisunla™ (donanemab-azbt) to include a new recommended titration dosing schedule for adults with early symptomatic Alzheimer disease.

Music therapy plus standard analgesia vs standard care alone reduced pain and anxiety in patients with nontrauma-related pain in the emergency department.

Nightly sleep duration greater than 9.9 hours in the first week postconcussion is associated with higher symptom burden among adolescents.